カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の代謝型グルタミン酸受容体1型（mGluR1）市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Metabotropic Glutamate Receptor 1 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO20809）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO20809
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の代謝型グルタミン酸受容体1型（mGluR1）市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

代謝型グルタミン酸受容体1型（mGluR1）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の代謝型グルタミン酸受容体1型（mGluR1）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

代謝型グルタミン酸受容体1型（mGluR1）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・FC-311、JBPOS-0101、VU-0467558、その他

用途別セグメントは次のように区分されます。
・うつ病、ディジョージ症候群、乳児けいれん、その他

世界の代謝型グルタミン酸受容体1型（mGluR1）市場の主要な市場プレーヤーは以下のとおりです。
・Aevi Genomic Medicine Inc、Biohaven Pharmaceutical Holding Company Ltd

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、代謝型グルタミン酸受容体1型（mGluR1）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な代謝型グルタミン酸受容体1型（mGluR1）メーカーの企業概要、2019年～2022年までの代謝型グルタミン酸受容体1型（mGluR1）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な代謝型グルタミン酸受容体1型（mGluR1）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別代謝型グルタミン酸受容体1型（mGluR1）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの代謝型グルタミン酸受容体1型（mGluR1）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での代謝型グルタミン酸受容体1型（mGluR1）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および代謝型グルタミン酸受容体1型（mGluR1）の産業チェーンを掲載しています。
・第13、14、15章では、代謝型グルタミン酸受容体1型（mGluR1）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 代謝型グルタミン酸受容体1型（mGluR1）の概要
- 種類別分析（2017年vs2021年vs2028年）：FC-311、JBPOS-0101、VU-0467558、その他
- 用途別分析（2017年vs2021年vs2028年）：うつ病、ディジョージ症候群、乳児けいれん、その他
- 世界の代謝型グルタミン酸受容体1型（mGluR1）市場規模・予測
- 世界の代謝型グルタミン酸受容体1型（mGluR1）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Aevi Genomic Medicine Inc、Biohaven Pharmaceutical Holding Company Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：FC-311、JBPOS-0101、VU-0467558、その他
・用途別分析2017年-2028年：うつ病、ディジョージ症候群、乳児けいれん、その他
・代謝型グルタミン酸受容体1型（mGluR1）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・代謝型グルタミン酸受容体1型（mGluR1）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・代謝型グルタミン酸受容体1型（mGluR1）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・代謝型グルタミン酸受容体1型（mGluR1）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・代謝型グルタミン酸受容体1型（mGluR1）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Metabotropic Glutamate Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Metabotropic Glutamate Receptor 1 market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Depression accounting for % of the Metabotropic Glutamate Receptor 1 global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While FC-311 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Metabotropic Glutamate Receptor 1 include Aevi Genomic Medicine Inc, Biohaven Pharmaceutical Holding Company Ltd, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Metabotropic Glutamate Receptor 1 market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
FC-311
JBPOS-0101
VU-0467558
Others
Market segment by Application can be divided into
Depression
DiGeorge Syndrome
Infantile Spasm
Others
The key market players for global Metabotropic Glutamate Receptor 1 market are listed below:
Aevi Genomic Medicine Inc
Biohaven Pharmaceutical Holding Company Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metabotropic Glutamate Receptor 1 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metabotropic Glutamate Receptor 1, with price, sales, revenue and global market share of Metabotropic Glutamate Receptor 1 from 2019 to 2022.
Chapter 3, the Metabotropic Glutamate Receptor 1 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metabotropic Glutamate Receptor 1 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Metabotropic Glutamate Receptor 1 market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metabotropic Glutamate Receptor 1.
Chapter 13, 14, and 15, to describe Metabotropic Glutamate Receptor 1 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Metabotropic Glutamate Receptor 1 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metabotropic Glutamate Receptor 1 Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 FC-311
1.2.3 JBPOS-0101
1.2.4 VU-0467558
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Metabotropic Glutamate Receptor 1 Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Depression
1.3.3 DiGeorge Syndrome
1.3.4 Infantile Spasm
1.3.5 Others
1.4 Global Metabotropic Glutamate Receptor 1 Market Size & Forecast
1.4.1 Global Metabotropic Glutamate Receptor 1 Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Metabotropic Glutamate Receptor 1 Sales in Volume (2017-2028)
1.4.3 Global Metabotropic Glutamate Receptor 1 Price (2017-2028)
1.5 Global Metabotropic Glutamate Receptor 1 Production Capacity Analysis
1.5.1 Global Metabotropic Glutamate Receptor 1 Total Production Capacity (2017-2028)
1.5.2 Global Metabotropic Glutamate Receptor 1 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metabotropic Glutamate Receptor 1 Market Drivers
1.6.2 Metabotropic Glutamate Receptor 1 Market Restraints
1.6.3 Metabotropic Glutamate Receptor 1 Trends Analysis
2 Manufacturers Profiles
2.1 Aevi Genomic Medicine Inc
2.1.1 Aevi Genomic Medicine Inc Details
2.1.2 Aevi Genomic Medicine Inc Major Business
2.1.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product and Services
2.1.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Biohaven Pharmaceutical Holding Company Ltd
2.2.1 Biohaven Pharmaceutical Holding Company Ltd Details
2.2.2 Biohaven Pharmaceutical Holding Company Ltd Major Business
2.2.3 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Product and Services
2.2.4 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Metabotropic Glutamate Receptor 1 Breakdown Data by Manufacturer
3.1 Global Metabotropic Glutamate Receptor 1 Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Metabotropic Glutamate Receptor 1 Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Metabotropic Glutamate Receptor 1
3.4 Market Concentration Rate
3.4.1 Top 3 Metabotropic Glutamate Receptor 1 Manufacturer Market Share in 2021
3.4.2 Top 6 Metabotropic Glutamate Receptor 1 Manufacturer Market Share in 2021
3.5 Global Metabotropic Glutamate Receptor 1 Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Metabotropic Glutamate Receptor 1 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metabotropic Glutamate Receptor 1 Market Size by Region
4.1.1 Global Metabotropic Glutamate Receptor 1 Sales in Volume by Region (2017-2028)
4.1.2 Global Metabotropic Glutamate Receptor 1 Revenue by Region (2017-2028)
4.2 North America Metabotropic Glutamate Receptor 1 Revenue (2017-2028)
4.3 Europe Metabotropic Glutamate Receptor 1 Revenue (2017-2028)
4.4 Asia-Pacific Metabotropic Glutamate Receptor 1 Revenue (2017-2028)
4.5 South America Metabotropic Glutamate Receptor 1 Revenue (2017-2028)
4.6 Middle East and Africa Metabotropic Glutamate Receptor 1 Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Metabotropic Glutamate Receptor 1 Sales in Volume by Type (2017-2028)
5.2 Global Metabotropic Glutamate Receptor 1 Revenue by Type (2017-2028)
5.3 Global Metabotropic Glutamate Receptor 1 Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Metabotropic Glutamate Receptor 1 Sales in Volume by Application (2017-2028)
6.2 Global Metabotropic Glutamate Receptor 1 Revenue by Application (2017-2028)
6.3 Global Metabotropic Glutamate Receptor 1 Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Metabotropic Glutamate Receptor 1 Sales by Type (2017-2028)
7.2 North America Metabotropic Glutamate Receptor 1 Sales by Application (2017-2028)
7.3 North America Metabotropic Glutamate Receptor 1 Market Size by Country
7.3.1 North America Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028)
7.3.2 North America Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Metabotropic Glutamate Receptor 1 Sales by Type (2017-2028)
8.2 Europe Metabotropic Glutamate Receptor 1 Sales by Application (2017-2028)
8.3 Europe Metabotropic Glutamate Receptor 1 Market Size by Country
8.3.1 Europe Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028)
8.3.2 Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Type (2017-2028)
9.2 Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Application (2017-2028)
9.3 Asia-Pacific Metabotropic Glutamate Receptor 1 Market Size by Region
9.3.1 Asia-Pacific Metabotropic Glutamate Receptor 1 Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Metabotropic Glutamate Receptor 1 Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Metabotropic Glutamate Receptor 1 Sales by Type (2017-2028)
10.2 South America Metabotropic Glutamate Receptor 1 Sales by Application (2017-2028)
10.3 South America Metabotropic Glutamate Receptor 1 Market Size by Country
10.3.1 South America Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028)
10.3.2 South America Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Type (2017-2028)
11.2 Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Application (2017-2028)
11.3 Middle East & Africa Metabotropic Glutamate Receptor 1 Market Size by Country
11.3.1 Middle East & Africa Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Metabotropic Glutamate Receptor 1 and Key Manufacturers
12.2 Manufacturing Costs Percentage of Metabotropic Glutamate Receptor 1
12.3 Metabotropic Glutamate Receptor 1 Production Process
12.4 Metabotropic Glutamate Receptor 1 Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Metabotropic Glutamate Receptor 1 Typical Distributors
13.3 Metabotropic Glutamate Receptor 1 Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Metabotropic Glutamate Receptor 1 Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Metabotropic Glutamate Receptor 1 Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Aevi Genomic Medicine Inc Basic Information, Manufacturing Base and Competitors
Table 4. Aevi Genomic Medicine Inc Major Business
Table 5. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product and Services
Table 6. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Biohaven Pharmaceutical Holding Company Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Biohaven Pharmaceutical Holding Company Ltd Major Business
Table 9. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Product and Services
Table 10. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Metabotropic Glutamate Receptor 1 Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 12. Global Metabotropic Glutamate Receptor 1 Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Metabotropic Glutamate Receptor 1, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Metabotropic Glutamate Receptor 1 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Metabotropic Glutamate Receptor 1 Production Site of Key Manufacturer
Table 16. Metabotropic Glutamate Receptor 1 New Entrant and Capacity Expansion Plans
Table 17. Metabotropic Glutamate Receptor 1 Mergers & Acquisitions in the Past Five Years
Table 18. Global Metabotropic Glutamate Receptor 1 Sales by Region (2017-2022) & (K Pcs)
Table 19. Global Metabotropic Glutamate Receptor 1 Sales by Region (2023-2028) & (K Pcs)
Table 20. Global Metabotropic Glutamate Receptor 1 Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Metabotropic Glutamate Receptor 1 Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 23. Global Metabotropic Glutamate Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 24. Global Metabotropic Glutamate Receptor 1 Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Metabotropic Glutamate Receptor 1 Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Metabotropic Glutamate Receptor 1 Price by Type (2017-2022) & (USD/Pcs)
Table 27. Global Metabotropic Glutamate Receptor 1 Price by Type (2023-2028) & (USD/Pcs)
Table 28. Global Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 29. Global Metabotropic Glutamate Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 30. Global Metabotropic Glutamate Receptor 1 Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Metabotropic Glutamate Receptor 1 Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Metabotropic Glutamate Receptor 1 Price by Application (2017-2022) & (USD/Pcs)
Table 33. Global Metabotropic Glutamate Receptor 1 Price by Application (2023-2028) & (USD/Pcs)
Table 34. North America Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 35. North America Metabotropic Glutamate Receptor 1 Sales by Country (2023-2028) & (K Pcs)
Table 36. North America Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Metabotropic Glutamate Receptor 1 Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 39. North America Metabotropic Glutamate Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 40. North America Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 41. North America Metabotropic Glutamate Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 42. Europe Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 43. Europe Metabotropic Glutamate Receptor 1 Sales by Country (2023-2028) & (K Pcs)
Table 44. Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 47. Europe Metabotropic Glutamate Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 48. Europe Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 49. Europe Metabotropic Glutamate Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 50. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Region (2017-2022) & (K Pcs)
Table 51. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Region (2023-2028) & (K Pcs)
Table 52. Asia-Pacific Metabotropic Glutamate Receptor 1 Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Metabotropic Glutamate Receptor 1 Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 55. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 56. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 57. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 58. South America Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 59. South America Metabotropic Glutamate Receptor 1 Sales by Country (2023-2028) & (K Pcs)
Table 60. South America Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Metabotropic Glutamate Receptor 1 Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 63. South America Metabotropic Glutamate Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 64. South America Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 65. South America Metabotropic Glutamate Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 66. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Region (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Region (2023-2028) & (K Pcs)
Table 68. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 71. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 72. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 73. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 74. Metabotropic Glutamate Receptor 1 Raw Material
Table 75. Key Manufacturers of Metabotropic Glutamate Receptor 1 Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Metabotropic Glutamate Receptor 1 Typical Distributors
Table 79. Metabotropic Glutamate Receptor 1 Typical Customers
List of Figures
Figure 1. Metabotropic Glutamate Receptor 1 Picture
Figure 2. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Type in 2021
Figure 3. FC-311
Figure 4. JBPOS-0101
Figure 5. VU-0467558
Figure 6. Others
Figure 7. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Application in 2021
Figure 8. Depression
Figure 9. DiGeorge Syndrome
Figure 10. Infantile Spasm
Figure 11. Others
Figure 12. Global Metabotropic Glutamate Receptor 1 Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 13. Global Metabotropic Glutamate Receptor 1 Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Metabotropic Glutamate Receptor 1 Sales (2017-2028) & (K Pcs)
Figure 15. Global Metabotropic Glutamate Receptor 1 Price (2017-2028) & (USD/Pcs)
Figure 16. Global Metabotropic Glutamate Receptor 1 Production Capacity (2017-2028) & (K Pcs)
Figure 17. Global Metabotropic Glutamate Receptor 1 Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Metabotropic Glutamate Receptor 1 Market Drivers
Figure 19. Metabotropic Glutamate Receptor 1 Market Restraints
Figure 20. Metabotropic Glutamate Receptor 1 Market Trends
Figure 21. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Manufacturer in 2021
Figure 22. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Manufacturer in 2021
Figure 23. Metabotropic Glutamate Receptor 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Metabotropic Glutamate Receptor 1 Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Metabotropic Glutamate Receptor 1 Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2017-2028)
Figure 27. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Region (2017-2028)
Figure 28. North America Metabotropic Glutamate Receptor 1 Revenue (2017-2028) & (USD Million)
Figure 29. Europe Metabotropic Glutamate Receptor 1 Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Metabotropic Glutamate Receptor 1 Revenue (2017-2028) & (USD Million)
Figure 31. South America Metabotropic Glutamate Receptor 1 Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue (2017-2028) & (USD Million)
Figure 33. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2028)
Figure 34. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Type (2017-2028)
Figure 35. Global Metabotropic Glutamate Receptor 1 Price by Type (2017-2028) & (USD/Pcs)
Figure 36. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2028)
Figure 37. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Application (2017-2028)
Figure 38. Global Metabotropic Glutamate Receptor 1 Price by Application (2017-2028) & (USD/Pcs)
Figure 39. North America Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2028)
Figure 40. North America Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2028)
Figure 41. North America Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2017-2028)
Figure 42. North America Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2017-2028)
Figure 43. United States Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2028)
Figure 47. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2028)
Figure 48. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2017-2028)
Figure 49. Europe Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2017-2028)
Figure 50. Germany Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Metabotropic Glutamate Receptor 1 Revenue Market Share by Region (2017-2028)
Figure 59. China Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2028)
Figure 66. South America Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2028)
Figure 67. South America Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2017-2028)
Figure 68. South America Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Metabotropic Glutamate Receptor 1 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 1 in 2021
Figure 80. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 1
Figure 81. Metabotropic Glutamate Receptor 1 Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医療用銅管（パイプ）市場2022年：市場規模予測（～2028年）
  • 世界の筋強直性ジストロフィー1型（DM1）市場2022年：市場規模予測（～2028年）
  • 世界のアンチトロンビン（組換え）市場2022年：市場規模予測（～2028年）
  • 世界の血栓活性剤（BCA）市場2022年：市場規模予測（～2028年）
  • 世界のマイクロニードル（極細針）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO20809 )"世界の代謝型グルタミン酸受容体1型（mGluR1）市場2022年：市場規模予測（～2028年）" (英文：Global Metabotropic Glutamate Receptor 1 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。